NCT01370343View on ClinicalTrials.gov

Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
HealthyDrug Interaction
Interventions
DRUG

PF-04991532 alone

a single dose of 150 mg PF-04991532, fasted

DRUG

PF-04991532 + cyclosporine

a single dose of 150 mg PF-04991532 + a single dose of 600 mg cyclosporine, fasted

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01370343 - Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers | Biotech Hunter | Biotech Hunter